Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Financial Flexibility Index
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥31.99 Million (operating CF CN¥15.48 Million minus capex CN¥16.52 Million) represents 0% of total liabilities (CN¥2.17 Billion). Also explore Zhejiang Hisoar Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Hisoar Pharmaceutical Co Ltd Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for Zhejiang Hisoar Pharmaceutical Co Ltd across 22 annual periods. Check 002099 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
Year-by-year free cash flow to debt coverage for Zhejiang Hisoar Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002099 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | CN¥296.94 Million | CN¥174.83 Million | CN¥2.32 Billion | ▼ -37.7% |
| 2023 | 0.21x | CN¥393.61 Million | CN¥240.54 Million | CN¥1.92 Billion | ▲ +58.9% |
| 2022 | 0.13x | CN¥295.52 Million | CN¥116.09 Million | CN¥2.29 Billion | ▼ -25.8% |
| 2021 | 0.17x | CN¥331.92 Million | CN¥102.36 Million | CN¥1.91 Billion | ▼ -62.0% |
| 2020 | 0.46x | CN¥608.05 Million | CN¥533.87 Million | CN¥1.33 Billion | ▼ -39.4% |
| 2019 | 0.76x | CN¥773.04 Million | CN¥612.40 Million | CN¥1.02 Billion | ▲ +18.7% |
| 2018 | 0.64x | CN¥1.05 Billion | CN¥791.45 Million | CN¥1.64 Billion | ▲ +488.2% |
| 2017 | 0.11x | CN¥251.67 Million | CN¥102.68 Million | CN¥2.32 Billion | ▼ -69.3% |
| 2016 | 0.35x | CN¥753.73 Million | CN¥629.42 Million | CN¥2.14 Billion | ▼ -41.5% |
| 2015 | 0.60x | CN¥758.52 Million | CN¥462.16 Million | CN¥1.26 Billion | ▲ +65.3% |
| 2014 | 0.36x | CN¥360.62 Million | CN¥191.56 Million | CN¥988.73 Million | ▲ +57.2% |
| 2013 | 0.23x | CN¥342.64 Million | CN¥60.85 Million | CN¥1.48 Billion | ▼ -54.9% |
| 2012 | 0.51x | CN¥607.51 Million | CN¥180.73 Million | CN¥1.18 Billion | ▲ +15.9% |
| 2011 | 0.44x | CN¥310.14 Million | CN¥92.62 Million | CN¥698.17 Million | ▼ -31.8% |
| 2010 | 0.65x | CN¥327.39 Million | CN¥180.88 Million | CN¥502.28 Million | ▲ +86.3% |
| 2009 | 0.35x | CN¥151.98 Million | CN¥98.38 Million | CN¥434.48 Million | ▲ +34.6% |
| 2008 | 0.26x | CN¥121.01 Million | CN¥30.61 Million | CN¥465.58 Million | ▼ -34.7% |
| 2007 | 0.40x | CN¥163.75 Million | CN¥51.14 Million | CN¥411.69 Million | ▼ -2.6% |
| 2006 | 0.41x | CN¥164.47 Million | CN¥61.88 Million | CN¥402.66 Million | ▲ +46.5% |
| 2005 | 0.28x | CN¥109.81 Million | CN¥36.07 Million | CN¥393.76 Million | ▼ -16.1% |
| 2004 | 0.33x | CN¥84.90 Million | CN¥42.36 Million | CN¥255.35 Million | ▲ +139.6% |
| 2003 | 0.14x | CN¥38.48 Million | CN¥-5.45 Million | CN¥277.36 Million | — |